Project MILANO: Connections Between Patients With Brain Tumors and Their Pets: an Analysis of Concerns and Needs

Study Purpose

Context and problem.In France, 61% of households own a pet, highlighting the significant role pets play in the daily lives. Patients diagnosed with brain tumors face specific challenges that may affect their ability to care their pets, including:

- Progressive neurological deficits (cognitive and/or motor), limiting their autonomy, - A life-threatening prognosis.

In this context, the well-being of pets when their owner's health deteriorates becomes a critical concern. Indeed:

- Social isolation and the progressive loss of physical and cognitive abilities complicate pet care, particularly during prolonged hospitalizations or in the event of death, - The lack of appropriate facilities and care solutions causes stress for pets, who are often unprepared for such transitions, and adds to the emotional burden on patients.

Why focus on patients with brain tumors?

- These patients have specific needs due to the rapid progression of their condition, - A local study showed that 12% of patients with gliomas live alone, a significantly higher rate than in other cancer types.

Patients who live alone are particularly exposed to issues related to their pet's future,

- Given the high morbidity and mortality associated with brain tumors, proactive planning for pet care is particularly urgent.

Recruitment Criteria

Accepts Healthy Volunteers Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms	No
Study Type An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes. An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes. Searching Both is inclusive of interventional and observational studies.	Observational
Eligible Ages	18 Years and Over
Gender	All

More Inclusion & Exclusion Criteria

Inclusion Criteria:

- Patients diagnosed with a brain tumor.

- Patients who own at least one pet.

Exclusion Criteria:

- Patients who decline to participate in the study.

- Patients unable to complete the questionnaire.

Trial Details

Trial ID: This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.	NCT06899516
Phase Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans. Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data. Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs. Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.
Lead Sponsor The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.	Centre Hospitalier Universitaire de Saint Etienne
Principal Investigator The person who is responsible for the scientific and technical direction of the entire clinical study.	Carole Ramirez, Md
Principal Investigator Affiliation	CHU de SAINT-ETIENNE
Agency Class Category of organization(s) involved as sponsor (and collaborator) supporting the trial.	Other
Overall Status	Recruiting
Countries	France
Conditions The disease, disorder, syndrome, illness, or injury that is being studied.	Brain (Nervous System) Cancers

Arms & Interventions

Arms

: Pet-owning brain tumour patients

To assess the concerns and needs of patients with brain tumors regarding their pets, in order to plan for the pets' future when their owners are hospitalized, unable to care for them due to their condition, or in the event of their death.

Interventions

Other: - The Lexington Attachment to Pets Scale (LAPS; Johnson, Garrity, & Stallones, 1992)

The LAPS is a established tool for measuring the emotional bond between humans and their animal companions. Animal attachment is assessed according to three factors: the bond between owners and their dogs or cats, the closeness of the human-animal relationship, and the importance of the animal in the owner's life (Johnson et al., 1992). Higher scores indicate greater attachment.

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

International Sites

CHU Saint Etienne, Saint-Étienne, France

Status

Recruiting

Address

CHU Saint Etienne

Saint-Étienne, , 42000

Site Contact

Carole Ramirez, Md

[email protected]

(0)477829326 #+33

Clinical Trial Finder